HCAL
NBIX icon

HURRICANE CAPITAL ADVISORS LLC’s Neurocrine Biosciences NBIX Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
+1,084
New +$161K 0.04% 382
2024
Q3 		– Sell
-2,675
Closed -$368K – 613
2024
Q2 		$368K Hold
2,675
– – 0.13% 118
2024
Q1 		$369K Buy
2,675
+1,653
+162% +$226K 0.1% 137
2023
Q4 		$135K Buy
+1,022
New +$118K 0.05% 224

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's NBIX Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 1,084 shares worth $183K. The stake represents 0.04% of the portfolio and ranks #382 among its holdings. This is a return to the name: HURRICANE CAPITAL ADVISORS LLC previously reported a position in NBIX as recently as Q2 2024.

HURRICANE CAPITAL ADVISORS LLC first reported a position in NBIX in Q4 2023 and has held it in 4 quarters since. The position peaked at $369K in Q1 2024. 785 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 1,084 shares of Neurocrine Biosciences worth $183K as of Q2 2026.
  • Neurocrine Biosciences was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
  • Neurocrine Biosciences made up 0.04% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #382 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Neurocrine Biosciences in Q4 2023 and has held it in 4 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Neurocrine Biosciences position peaked at $369K in Q1 2024.
  • 785 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.